|
The document is a final report on an in vitro mammalian chromosome aberration study conducted by BioReliance for E. I. duPont de Nemours and Company, focusing on the effects of a test substance, likely related to PFOA or PFOS, on human peripheral blood lymphocytes, with compliance to Good Laboratory Practice standards noted.
|
— |
AR226-3309
|
peZRj6mo9bGEvap7VzJm1MyrB |
40 |